Last reviewed · How we verify
NCT03658590
Dexamethasone and Induction of Delivery
Phase 1 trial testing Dexamethasone in Induction of Labor Affected Fetus / Newborn in 102 participants. Completed in 30 June 2018.
15 April 2018
Quick facts
| Lead sponsor | samar sayed el sayed |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 102 |
| Start date | 1 January 2018 |
| Primary completion | 15 April 2018 |
| Estimated completion | 30 June 2018 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Dexamethasone (dexamethasone) — full drug profile →
- Distilled Water — full drug profile →
Conditions studied
- Induction of Labor Affected Fetus / Newborn — all drugs for Induction of Labor Affected Fetus / Newborn →
Sponsor
samar sayed el sayed
Who can join
Eligibility, female only, with Induction of Labor Affected Fetus / Newborn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of intravenous injection of a single dose of dexamethasone in shortening the duration interval between initiation of labor induction and delivery of the fetus in primigravida full-term pregnancy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03658590
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexamethasone
Trials testing the same drug.
- NCT07543458 — Therapeutics for Moderate and Severe Dengue · Phase 3 · not yet recruiting
- NCT07175415 — HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological · Phase 1, PHASE2 · not yet recruiting
- NCT07513129 — A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients · Phase 1 · not yet recruiting
- NCT07444710 — Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) · Phase 1 · not yet recruiting
- NCT07387926 — Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+ · Phase 1, PHASE2 · not yet recruiting
Other recruiting trials for Induction of Labor Affected Fetus / Newborn
Currently open trials in the same condition.
- NCT06375746 — The Impact of a Customized Informative Video Prior to Induction of Labor on Anxiety Relieve. · NA · recruiting
- NCT06325007 — Castor Oil Ingestion and Balloon Catheter for Labor Induction in Nulliparous · NA · recruiting
- NCT06187779 — Induction ATAD Catheter and Lower Segment Thickness · NA · active not recruiting
- NCT05759988 — Cervical Ripening as an Outpatient Method Using the Foley (COMFORT) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03658590 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by samar sayed el sayed
- Last refreshed: 5 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03658590.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing